Verastem | VSTM - Kısa Vadeli Yükümlülükler





Kısa Vadeli Yükümlülükler Değişiklik Tarih
AbbVie USD 43.29B 3.9B 2025-12
Alaunos Therapeutics USD 813K 108K 2025-12
AstraZeneca USD 32.57B 1.95B 2026-03
Curis USD 14.08M 5.3M 2025-12
Cytokinetics USD 199.18M 3.27M 2026-03
Gilead Sciences USD 11.81B 485M 2025-12
Incyte USD 1.49B 25.52M 2026-03
Laboratory Of America USD 2.64B 182.5M 2026-03
Novartis USD 31.37B 4.1B 2026-03
Pfizer USD 34.35B 2.64B 2026-03
Roche Holding CHF 28B 421M 2025-12
TG Therapeutics USD 153.76M 3.05M 2025-12
Verastem USD 72.27M 12.56M 2025-12